ALKEM — Alkem Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹566.16bn
- IN₹546.06bn
- IN₹115.99bn
- 97
- 17
- 99
- 87
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 73,572 | 83,444 | 88,650 | 106,342 | 115,993 |
Cost of Revenue | |||||
Gross Profit | 42,952 | 49,248 | 52,759 | 63,704 | 66,688 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 63,966 | 70,574 | 71,955 | 88,627 | 103,201 |
Operating Profit | 9,606 | 12,870 | 16,695 | 17,715 | 12,792 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9,547 | 12,598 | 18,421 | 18,443 | 13,048 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7,736 | 11,493 | 16,178 | 16,803 | 10,068 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 7,605 | 11,271 | 15,850 | 16,456 | 9,842 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7,605 | 11,271 | 15,850 | 16,456 | 9,842 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 64 | 94.4 | 130 | 138 | 89.9 |
Dividends per Share | |||||
Special Dividends per Share |